These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2157676)

  • 21. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphology of interleukin-2-stimulated human peripheral blood mononuclear effector cells killing glioma-derived tumor cells in vitro.
    Hook GR; Greenwood MA; Barba D; Ikejiri B; Chen SN; Oldfield EH; Weber RJ; Muul LM
    J Natl Cancer Inst; 1988 Apr; 80(3):171-7. PubMed ID: 3258038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A study of perforin appearing in human lymphokine-activated killer (LAK) cells derived from spleen and peripheral blood mononuclear cells].
    Kataoka K
    Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):352-62. PubMed ID: 1603043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Infiltrative and cytolytic activities of lymphokine-activated killer (LAK) cells against a human glioma mass: ultrastructural analysis using a three-dimensional multicellular spheroid model].
    Iwasaki K
    Nihon Geka Hokan; 1990 Jan; 59(1):39-54. PubMed ID: 2130768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcellular localization of perforin and serine esterase in lymphokine-activated killer cells and cytotoxic T cells by immunogold labeling.
    Ojcius DM; Zheng LM; Sphicas EC; Zychlinsky A; Young JD
    J Immunol; 1991 Jun; 146(12):4427-32. PubMed ID: 2040805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
    Dannemann BR; Morris VA; Araujo FG; Remington JS
    J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Culture medium induced morphological changes of melanoma cells associated with change in sensitivity to lysis by lymphokine-activated killer cells.
    Perng YP; Lin CC; Perng IM; Shen YC; Chuang CK; Liao SK
    Cancer Biother Radiopharm; 1997 Oct; 12(5):317-31. PubMed ID: 10851482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA-protein cell content of lymphokine activated killer (LAK) and target cells in coculture.
    Nano R; Barni S; Capelli E; Prosperi E; Lavezzi L; Salvucci O
    Anticancer Res; 1995; 15(3):751-4. PubMed ID: 7645953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of membrane-associated cytotoxic proteins to cytolysis of L929 and K562 target cells mediated by LAK cells with different phenotypes.
    Saschenko LP; Gnuchev NV; Redchenko IV; Kabanova OD; Lukjianova TI; Blishchenko LYu ; Satpaev DK; Chertov OYu
    Immunol Lett; 1994 Mar; 39(3):243-7. PubMed ID: 8034339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro.
    Higuchi CM; Thompson JA; Lindgren CG; Gillis S; Widmer MB; Kern DE; Fefer A
    Cancer Res; 1989 Dec; 49(23):6487-92. PubMed ID: 2479463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.
    Gamero AM; Ussery D; Reintgen DS; Puleo CA; Djeu JY
    Cancer Res; 1995 Nov; 55(21):4988-94. PubMed ID: 7585540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
    Lynch DH; Miller RE
    J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granzyme B-mRNA expression by equine lymphokine activated killer (LAK) cells is associated with the induction of apoptosis in target cells.
    Liu C; Betancourt A; Cohen DA; Adams AA; Sun L; Horohov DW
    Vet Immunol Immunopathol; 2011 Sep; 143(1-2):108-15. PubMed ID: 21802151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells.
    Gunji Y; Lewis J; Gorelik E
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):663-72. PubMed ID: 2133246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y; Bonavida B; Nio Y; Yoshida O
    Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing.
    Atzpodien J; Gulati SC; Shimazaki C; Bührer C; Oz S; Kwon JH; Kolitz JE; Clarkson BD
    Oncology; 1988; 45(6):437-43. PubMed ID: 3263598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between lymphokine activated killer cells generated in the presence of cisplatin/FK-565 and tumor cells: transmission electron microscopy analysis.
    Basu S; Sodhi A
    Anticancer Drugs; 1992 Apr; 3(2):155-62. PubMed ID: 1525394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient generation and characterization of tumor cell subclones with different adhesion pathways involved in cell lysis.
    Lefterova P; Negrin R; Neubauer A; Huhn D; Blume K; Schmidt-Wolf I
    Haematologica; 1993; 78(6):353-8. PubMed ID: 8175030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognition.
    Mueller EA; Anderer FA
    Cancer Res; 1990 Jun; 50(12):3646-51. PubMed ID: 1692765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.